Empirical Wealth Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$288K Buy
1,401
+148
+12% +$29.3K ﹤0.01% 976
2026
Q2
$235K Buy
+1,253
New +$183K ﹤0.01% 965

Other funds holding RVMD

Empirical Wealth Management's RVMD Position: Q3 2026 in Review

Empirical Wealth Management increased its Revolution Medicines (RVMD) stake by 12% in Q3 2026, buying an estimated $29.3K and bringing the position to 1,401 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Empirical Wealth Management first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 759 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Empirical Wealth Management held 1,401 shares of Revolution Medicines worth $288K as of Q3 2026.
  • Empirical Wealth Management bought 148 Revolution Medicines shares in Q3 2026, an estimated $29.3K.
  • Revolution Medicines made up ﹤0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #976 holding.
  • Empirical Wealth Management first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 759 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.